Table 1.
Inhibition of L. theobromae and C. gloeosporiodes by the antagonistic yeast strains on PDA with different nutrient concentrations at 25 °C for 3 and 14 days, respectively.
| Treatment | Fungal Pathogens Growth Inhibition (%) a | |||
|---|---|---|---|---|
| 39.0 g/L PDA Powder | 19.5 g/L PDA Powder | 9.7 g/L PDA Powder | 3.9 g/L PDA Powder | |
| T. indica DMKU-RP31 + L. theobromae | 65.6 ± 1.87bc | 67.3 ± 0.99b | 70.8 ± 1.69ab | 75.6 ± 3.24a |
| T. indica DMKU-RP35 + L. theobromae | 67.7 ± 0.90b | 68.6 ± 0.57b | 70.8 ± 3.56ab | 76.0 ± 4.68a |
| Ps. hubeiensis YE-21 + L. theobromae | 58.4 ± 1.87d | 61.7 ± 1.14cd | 62.0 ± 3.56cd | 69.7 ± 5.15b |
| P. aspenensis DMKU-SP67 + C. gloeosporiodes | 64.6 ± 3.72c | 68.1 ± 0.57bc | 71.3 ± 1.71b | 75.7 ± 1.36a |
In the same row data followed by the different, same, and overlapping lower-case letters means significantly different, and no significantly different of their overlapping to Duncan’s multiple range test at p ≤ 0.05. Each result presents the mean ± standard derivation from three replicates. a Inhibition (%) = (radius of control fungal colony − radius of fungal colony grows with yeast) × 100/radius of control fungal colony.